(NASDAQ:TCRT) ALAUNOS THERAPEUDICS INC. shares are climbing today in the pre-market up more than 31% on an astounding 36,000 trades and climbing.

Details for the presentation are below:

Event: Jefferies 2022 Global Healthcare ConferenceDate: Friday, June 10, 2022Time: 9:00-9:25 am ETLocation: New York Marriott MarquisRoom: Track 6

A live webcast of the presentation will be accessible on the Company’s website in the Investors section under Events & Presentations at www.alaunos.com or by using the link here. A replay of the webcast will be available on the Alaunos website for approximately 90 days following the presentation.About Alaunos TherapeuticsAlaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer technology and its TCR library targeting shared tumor-specific hotspot mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute. For more information, please visit www.alaunos.com. Alex Lobo Alex.lobo@sternir.com